Skip to main content
    N

    NextCure  Inc (NXTC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.68
    +0.28 (+4.38%)

    Market Cap: $29.31M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NextCure  Inc (NXTC) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    NextCure (NXTC) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, NextCure reported EPS of -$1.67, below the -$0.90 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(16/31)
    Avg Surprise
    -22.87%

    Upcoming Estimates

    Reports Mar 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.44
    Range-$1.98 - -$0.83
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$2.23
    Range-$2.23 - -$2.23
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$2.20-1.4%
    60d ago-$2.18-2.3%
    30d ago-$2.18-2.3%
    7d ago-$2.18-2.3%
    Current-$2.23
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    NXTC has an expected report date of Mar 3, 2027.

    Earnings History

    Of the 31 quarters below that had an estimate, NXTC beat 16 and missed 15. The widest gap in the table came in the quarter ended Mar 31, 2019, when EPS landed 741.51% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.67-$0.90-$0.90 - -$0.90-85.56%MissN/A10 up, 0 downNov 10, 2026N/A
    Jun 30, 2026-$1.84-$1.98-$2.03 - -$1.84+7.07%BeatN/A40 up, 0 downAug 6, 2026N/A
    Mar 31, 2026-$1.87-$2.03-$2.40 - -$1.81+7.88%BeatN/A32 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$0.81-$2.29-$2.38 - -$2.14+64.63%BeatN/A33 up, 0 downMar 5, 2026N/A
    Sep 30, 2025-$3.22-$4.06-$4.47 - -$3.65+20.69%BeatN/A31 up, 0 downNov 5, 2025N/A
    Jun 30, 2025-$11.29-$4.62-$4.68 - -$4.55-144.37%MissN/A21 up, 0 downAug 7, 2025N/A
    Mar 31, 2025-$4.68-$4.80-$5.04 - -$4.56+2.50%BeatN/A20 up, 1 downMay 1, 2025N/A
    Dec 31, 2024-$0.41-$0.36-$0.36 - -$0.36-13.89%MissN/A10 up, 1 downMar 6, 2025$3.28M
    Sep 30, 2024-$4.92-$3.84-$4.44 - -$3.84-28.13%MissN/A20 up, 0 downNov 7, 2024N/A
    Jun 30, 2024-$6.60-$4.95N/A-33.33%MissN/A30 up, 0 downAug 1, 2024N/A
    Mar 31, 2024-$6.26-$5.52-$6.12 - -$5.16-13.41%MissN/A40 up, 0 downMay 2, 2024N/A
    Dec 31, 2023-$0.52-$0.54-$0.59 - -$0.48+3.70%BeatN/A40 up, 0 downMar 21, 2024$6.28M
    Sep 30, 2023-$6.12-$7.84-$8.16 - -$7.56+21.94%BeatN/A40 up, 0 downNov 2, 2023N/A
    Jun 30, 2023-$7.68-$7.20-$7.20 - -$6.84-6.67%MissN/A30 up, 0 downAug 3, 2023N/A
    Mar 31, 2023-$6.96-$7.44-$8.40 - -$7.08+6.45%BeatN/A40 up, 0 downMay 4, 2023N/A
    Dec 31, 2022-$0.62-$0.66-$0.76 - -$0.59+6.06%BeatN/A60 up, 0 downMar 2, 2023N/A
    Sep 30, 2022-$8.16-$7.80-$8.76 - -$5.04-4.62%MissN/A70 up, 0 downNov 3, 2022N/A
    Jun 30, 2022-$7.80-$9.02-$9.36 - -$7.68+13.53%BeatN/A60 up, 0 downAug 4, 2022N/A
    Mar 31, 2022-$8.88-$8.02-$8.28 - -$7.68-10.72%MissN/A60 up, 0 downMay 5, 2022N/A
    Dec 31, 2021-$0.61-$0.67-$0.74 - -$0.54+8.96%BeatN/A8N/AMar 3, 2022N/A
    Sep 30, 2021-$7.80-$7.97-$8.40 - -$7.68+2.13%BeatN/A9N/ANov 4, 2021N/A
    Jun 30, 2021-$7.80-$7.44-$7.80 - -$6.72-4.84%MissN/A7N/AAug 5, 2021N/A
    Mar 31, 2021-$7.20-$7.15-$8.16 - -$6.48-0.70%Miss-2281.8%6N/AMay 6, 2021N/A
    Dec 31, 2020-$0.54-$0.60-$0.66 - -$0.50+10.00%BeatN/A9N/AMar 4, 2021N/A
    Sep 30, 2020-$7.08-$6.52-$8.64 - -$5.28-8.59%MissN/A8N/ANov 5, 2020N/A
    Jun 30, 2020-$6.36-$5.82-$7.56 - -$4.20-9.28%MissN/A9N/AAug 6, 2020N/A
    Mar 31, 2020$0.33-$0.44-$1.31 - $0.23+175.00%BeatN/A7N/AMay 7, 2020$22.38M
    Dec 31, 2019-$4.08-$8.46-$12.85 - -$3.60+51.77%BeatN/A7N/AMar 12, 2020$2.00M
    Sep 30, 2019-$4.44-$4.08-$4.32 - -$4.08-8.82%MissN/A2N/ANov 12, 2019$1.58M
    Jun 30, 2019-$7.32-$7.56-$7.56 - -$3.60+3.17%BeatN/A2N/AAug 12, 2019$1.40M
    Mar 31, 2019-$4.46-$0.53N/A-741.51%MissN/AN/AN/AJun 10, 2019$1.36M
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$20.00, after -$18.19 the year before. It was -$20.30 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$20.00N/A
    Dec 31, 2024-$18.19N/A
    Dec 31, 2023-$21.28N/A
    Dec 31, 2022-$25.46N/A
    Dec 31, 2021-$23.41N/A
    Dec 31, 2020-$13.65N/A
    Dec 31, 2019-$20.30N/A

    Frequently Asked Questions About NXTC

    When is NextCure's next earnings date?

    NextCure's next earnings report is expected for Mar 3, 2027.

    Did NXTC beat earnings estimates last quarter?

    No. NextCure reported EPS of -$1.67 for the quarter ended Sep 30, 2026, below the -$0.90 estimate by 85.56%.

    What EPS do analysts expect from NXTC next quarter?

    The consensus EPS estimate for NextCure for the quarter ending Dec 31, 2026 is -$1.44 from 4 analysts, with estimates from -$1.98 to -$0.83.

    How often does NXTC beat earnings estimates?

    NextCure beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -17.63%.